English

Implant Sciences Corp

EDGAR

Quarterly report (10-Q) · filed 2017-05-30

115 filing records in this dataset, filed from 1999-06-14 to 2017-05-30. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

206 thousand USD

2017 Q3 · USD

Exact inputs and evidence

Revenue: 206000 USD Source

Operating cash flow

-16 million USD

2017 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -21937000 USD Source
Operating Cash Flow: -5916000 USD Source

Cash and cash equivalents: 72.8 million USD 2017-03-31 Source
Exact value

72752000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

117 thousand USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Capital expenditure: 15000 USD · 2010-07-01 – 2010-12-31 Source
Capital expenditure: 0 USD · 2010-07-01 – 2010-09-30 Source
Capital expenditure: 43000 USD · 2010-07-01 – 2011-03-31 Source
Capital expenditure: 15000 USD · 2010-07-01 – 2010-12-31 Source
Capital expenditure: 59000 USD · 2010-07-01 – 2011-06-30 Source
Capital expenditure: 43000 USD · 2010-07-01 – 2011-03-31 Source
Capital expenditure: 58000 USD · 2011-07-01 – 2011-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-05-30.

Financial data available through: 2016-09-30.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2016-09-30
Operating income: 5 of 11 periods available· newest 2011-06-30
Net income: 11 of 11 periods available· newest 2016-09-30
Operating cash flow: 11 of 11 periods available· newest 2016-09-30
Capital expenditure: 5 of 11 periods available· newest 2011-06-30
Total assets: 11 of 11 periods available· newest 2016-09-30
Total liabilities: 11 of 11 periods available· newest 2016-09-30
Current assets: 11 of 11 periods available· newest 2016-09-30
Current liabilities: 11 of 11 periods available· newest 2016-09-30
Cash and cash equivalents: 11 of 11 periods available· newest 2016-09-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-44%

Prior period

USD 14.39 million

2014-10-01 – 2015-09-30
Current period

USD 8.06 million

2015-10-01 – 2016-09-30

Exact inputs and evidence

8062000 − 14393000 = -6331000 USD

14393000 USD · 2014-10-01 – 2015-09-30
Inspect prior input Prior source
8062000 USD · 2015-10-01 – 2016-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Implant Sciences Corp · 2016-09-30 Implant Sciences Corp (edgar:1068874) Year-over-year change in Revenue: -6331000 USD Concept: fundies:Revenue Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 8062000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#17768 Filing: 000106887416000139 Input fundies:Revenue: 14393000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#17870 Filing: 000106887416000139
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 26.27 million

Prior period

−USD 911,000

2014-10-01 – 2015-09-30
Current period

−USD 27.18 million

2015-10-01 – 2016-09-30

Exact inputs and evidence

-27184000 − -911000 = -26273000 USD

-911000 USD · 2014-10-01 – 2015-09-30
Inspect prior input Prior source
-27184000 USD · 2015-10-01 – 2016-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Implant Sciences Corp · 2016-09-30 Implant Sciences Corp (edgar:1068874) Year-over-year change in Net income: -26273000 USD Concept: fundies:NetIncome Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -27184000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#20273 Filing: 000106887416000139 Input fundies:NetIncome: -911000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#20387 Filing: 000106887416000139
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.23 million

Prior period

−USD 1.27 million

2014-10-01 – 2015-09-30
Current period

−USD 40,000

2015-10-01 – 2016-09-30

Exact inputs and evidence

-40000 − -1268000 = 1228000 USD

-1268000 USD · 2014-10-01 – 2015-09-30
Inspect prior input Prior source
-40000 USD · 2015-10-01 – 2016-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Implant Sciences Corp · 2016-09-30 Implant Sciences Corp (edgar:1068874) Year-over-year change in Operating cash flow: 1228000 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -40000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#13576 Filing: 000106887416000139 Input fundies:OperatingCashFlow: -1268000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#13745 Filing: 000106887416000139
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2015-10-01 – 2016-09-30

Revenue USD 8.06 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 27.18 million −337% of revenue

Cash

Operating cash flow −USD 40,000 −0.5% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 243% of revenue.
2010 Operating loss: operating costs were 196% of revenue.
2011 Operating loss: operating costs were 188% of revenue.
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2008-07-01 – 2009-06-30	8737000	21216000 Derived	-12479000	272000 Derived	-12751000	-4121000 Derived	Source 2008-07-01 – 2009-06-30: 8737000 USD Inspect Revenue Open source 2008-07-01 – 2009-06-30: -12479000 USD Inspect Operating Income Open source 2008-07-01 – 2009-06-30: -12751000 USD Inspect Net Income Open source 2008-07-01 – 2009-06-30: -4018000 USD Inspect Operating Cash Flow Open source 2008-07-01 – 2009-06-30: 103000 USD Inspect Capital Expenditure Open source
2010 2009-07-01 – 2010-06-30	3474000	6802000 Derived	-3328000	12195000 Derived	-15523000	-7954000 Derived	Source 2009-07-01 – 2010-06-30: 3474000 USD Inspect Revenue Open source 2009-07-01 – 2010-06-30: -3328000 USD Inspect Operating Income Open source 2009-07-01 – 2010-06-30: -15523000 USD Inspect Net Income Open source 2009-07-01 – 2010-06-30: -7944000 USD Inspect Operating Cash Flow Open source 2009-07-01 – 2010-06-30: 10000 USD Inspect Capital Expenditure Open source
2011 2010-07-01 – 2011-06-30	6652000	12476000 Derived	-5824000	9730000 Derived	-15554000	-7986000 Derived	Source 2010-07-01 – 2011-06-30: 6652000 USD Inspect Revenue Open source 2010-07-01 – 2011-06-30: -5824000 USD Inspect Operating Income Open source 2010-07-01 – 2011-06-30: -15554000 USD Inspect Net Income Open source 2010-07-01 – 2011-06-30: -7927000 USD Inspect Operating Cash Flow Open source 2010-07-01 – 2011-06-30: 59000 USD Inspect Capital Expenditure Open source
2012 2011-07-01 – 2012-06-30	3406000	Unavailable	Unavailable	Unavailable	-14636000	Unavailable	Source 2011-07-01 – 2012-06-30: 3406000 USD Inspect Revenue Open source 2011-07-01 – 2012-06-30: -14636000 USD Inspect Net Income Open source 2011-07-01 – 2012-06-30: -10536000 USD Inspect Operating Cash Flow Open source
2013 2012-07-01 – 2013-06-30	12017000	Unavailable	Unavailable	Unavailable	-27354000	Unavailable	Source 2012-07-01 – 2013-06-30: 12017000 USD Inspect Revenue Open source 2012-07-01 – 2013-06-30: -27354000 USD Inspect Net Income Open source 2012-07-01 – 2013-06-30: -10890000 USD Inspect Operating Cash Flow Open source
2014 2013-07-01 – 2014-06-30	8552000	Unavailable	Unavailable	Unavailable	-21010000	Unavailable	Source 2013-07-01 – 2014-06-30: 8552000 USD Inspect Revenue Open source 2013-07-01 – 2014-06-30: -21010000 USD Inspect Net Income Open source 2013-07-01 – 2014-06-30: -9989000 USD Inspect Operating Cash Flow Open source
2015 2014-07-01 – 2015-06-30	12991000	Unavailable	Unavailable	Unavailable	-21543000	Unavailable	Source 2014-07-01 – 2015-06-30: 12991000 USD Inspect Revenue Open source 2014-07-01 – 2015-06-30: -21543000 USD Inspect Net Income Open source 2014-07-01 – 2015-06-30: -12150000 USD Inspect Operating Cash Flow Open source
2016 2014-10-01 – 2015-09-30	14393000	Unavailable	Unavailable	Unavailable	-911000	Unavailable	Source 2014-10-01 – 2015-09-30: 14393000 USD Inspect Revenue Open source 2014-10-01 – 2015-09-30: -911000 USD Inspect Net Income Open source 2014-10-01 – 2015-09-30: -1268000 USD Inspect Operating Cash Flow Open source
2016 2015-07-01 – 2016-06-30	53061000	Unavailable	Unavailable	Unavailable	-10655000	Unavailable	Source 2015-07-01 – 2016-06-30: 53061000 USD Inspect Revenue Open source 2015-07-01 – 2016-06-30: -10655000 USD Inspect Net Income Open source 2015-07-01 – 2016-06-30: -1487000 USD Inspect Operating Cash Flow Open source
2017 2015-10-01 – 2016-09-30	8062000	Unavailable	Unavailable	Unavailable	-27184000	Unavailable	Source 2015-10-01 – 2016-09-30: 8062000 USD Inspect Revenue Open source 2015-10-01 – 2016-09-30: -27184000 USD Inspect Net Income Open source 2015-10-01 – 2016-09-30: -40000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 8.1M 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-06-30	Revenue	8737000	Revenue: 8737000 Open source
20102010-06-30	Revenue	3474000	Revenue: 3474000 Open source
20112011-06-30	Revenue	6652000	Revenue: 6652000 Open source
20122012-06-30	Revenue	3406000	Revenue: 3406000 Open source
20132013-06-30	Revenue	12017000	Revenue: 12017000 Open source
20142014-06-30	Revenue	8552000	Revenue: 8552000 Open source
20152015-06-30	Revenue	12991000	Revenue: 12991000 Open source
20162015-09-30	Revenue	14393000	Revenue: 14393000 Open source
20162016-06-30	Revenue	53061000	Revenue: 53061000 Open source
20172016-09-30	Revenue	8062000	Revenue: 8062000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-44% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Year over year	69.6%	Revenue: 8737000 Open source Revenue: 5152000 Open source
20102010-06-30	Year over year	-60.2%	Revenue: 3474000 Open source Revenue: 8737000 Open source
20112011-06-30	Year over year	91.5%	Revenue: 6652000 Open source Revenue: 3474000 Open source
20122012-06-30	Year over year	-48.8%	Revenue: 3406000 Open source Revenue: 6652000 Open source
20132013-06-30	Year over year	252.8%	Revenue: 12017000 Open source Revenue: 3406000 Open source
20142014-06-30	Year over year	-28.8%	Revenue: 8552000 Open source Revenue: 12017000 Open source
20152015-06-30	Year over year	51.9%	Revenue: 12991000 Open source Revenue: 8552000 Open source
20162015-09-30	Year over year	No prior comparable period	Revenue: 14393000 Open source
20162016-06-30	Year over year	308.4%	Revenue: 53061000 Open source Revenue: 12991000 Open source
20172016-09-30	Year over year	-44%	Revenue: 8062000 Open source Revenue: 14393000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -87.6% 2011

Net margin -337.2% 2017

Free cash flow margin -120.1% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Operating margin	-142.8%	Operating Income: -12479000 Open source Revenue: 8737000 Open source
20102010-06-30	Operating margin	-95.8%	Operating Income: -3328000 Open source Revenue: 3474000 Open source
20112011-06-30	Operating margin	-87.6%	Operating Income: -5824000 Open source Revenue: 6652000 Open source
2012-06-30	Operating margin	Not reported	Revenue: 3406000 Open source
2013-06-30	Operating margin	Not reported	Revenue: 12017000 Open source
2014-06-30	Operating margin	Not reported	Revenue: 8552000 Open source
2015-06-30	Operating margin	Not reported	Revenue: 12991000 Open source
2015-09-30	Operating margin	Not reported	Revenue: 14393000 Open source
2016-06-30	Operating margin	Not reported	Revenue: 53061000 Open source
2016-09-30	Operating margin	Not reported	Revenue: 8062000 Open source
20092009-06-30	Net margin	-145.9%	Net Income: -12751000 Open source Revenue: 8737000 Open source
20102010-06-30	Net margin	-446.8%	Net Income: -15523000 Open source Revenue: 3474000 Open source
20112011-06-30	Net margin	-233.8%	Net Income: -15554000 Open source Revenue: 6652000 Open source
20122012-06-30	Net margin	-429.7%	Net Income: -14636000 Open source Revenue: 3406000 Open source
20132013-06-30	Net margin	-227.6%	Net Income: -27354000 Open source Revenue: 12017000 Open source
20142014-06-30	Net margin	-245.7%	Net Income: -21010000 Open source Revenue: 8552000 Open source
20152015-06-30	Net margin	-165.8%	Net Income: -21543000 Open source Revenue: 12991000 Open source
20162015-09-30	Net margin	-6.3%	Net Income: -911000 Open source Revenue: 14393000 Open source
20162016-06-30	Net margin	-20.1%	Net Income: -10655000 Open source Revenue: 53061000 Open source
20172016-09-30	Net margin	-337.2%	Net Income: -27184000 Open source Revenue: 8062000 Open source
20092009-06-30	Free cash flow margin	-47.2%	Revenue: 8737000 Open source Operating Cash Flow: -4018000 Open source Capital Expenditure: 103000 Open source
20102010-06-30	Free cash flow margin	-229%	Revenue: 3474000 Open source Operating Cash Flow: -7944000 Open source Capital Expenditure: 10000 Open source
20112011-06-30	Free cash flow margin	-120.1%	Revenue: 6652000 Open source Operating Cash Flow: -7927000 Open source Capital Expenditure: 59000 Open source
20122012-06-30	Free cash flow margin	Not reported	Revenue: 3406000 Open source Operating Cash Flow: -10536000 Open source
20132013-06-30	Free cash flow margin	Not reported	Revenue: 12017000 Open source Operating Cash Flow: -10890000 Open source
20142014-06-30	Free cash flow margin	Not reported	Revenue: 8552000 Open source Operating Cash Flow: -9989000 Open source
20152015-06-30	Free cash flow margin	Not reported	Revenue: 12991000 Open source Operating Cash Flow: -12150000 Open source
20162015-09-30	Free cash flow margin	Not reported	Revenue: 14393000 Open source Operating Cash Flow: -1268000 Open source
20162016-06-30	Free cash flow margin	Not reported	Revenue: 53061000 Open source Operating Cash Flow: -1487000 Open source
20172016-09-30	Free cash flow margin	Not reported	Revenue: 8062000 Open source Operating Cash Flow: -40000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -40K 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-06-30	Operating cash flow	-4018000	Operating Cash Flow: -4018000 Open source
20102010-06-30	Operating cash flow	-7944000	Operating Cash Flow: -7944000 Open source
20112011-06-30	Operating cash flow	-7927000	Operating Cash Flow: -7927000 Open source
20122012-06-30	Operating cash flow	-10536000	Operating Cash Flow: -10536000 Open source
20132013-06-30	Operating cash flow	-10890000	Operating Cash Flow: -10890000 Open source
20142014-06-30	Operating cash flow	-9989000	Operating Cash Flow: -9989000 Open source
20152015-06-30	Operating cash flow	-12150000	Operating Cash Flow: -12150000 Open source
20162015-09-30	Operating cash flow	-1268000	Operating Cash Flow: -1268000 Open source
20162016-06-30	Operating cash flow	-1487000	Operating Cash Flow: -1487000 Open source
20172016-09-30	Operating cash flow	-40000	Operating Cash Flow: -40000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -8M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-06-30	Free cash flow	-4121000	Operating Cash Flow: -4018000 Open source Capital Expenditure: 103000 Open source
20102010-06-30	Free cash flow	-7954000	Operating Cash Flow: -7944000 Open source Capital Expenditure: 10000 Open source
20112011-06-30	Free cash flow	-7986000	Operating Cash Flow: -7927000 Open source Capital Expenditure: 59000 Open source
20122012-06-30	Free cash flow	Unavailable	Operating Cash Flow: -10536000 Open source
20132013-06-30	Free cash flow	Unavailable	Operating Cash Flow: -10890000 Open source
20142014-06-30	Free cash flow	Unavailable	Operating Cash Flow: -9989000 Open source
20152015-06-30	Free cash flow	Unavailable	Operating Cash Flow: -12150000 Open source
20162015-09-30	Free cash flow	Unavailable	Operating Cash Flow: -1268000 Open source
20162016-06-30	Free cash flow	Unavailable	Operating Cash Flow: -1487000 Open source
20172016-09-30	Free cash flow	Unavailable	Operating Cash Flow: -40000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

783.6% 2017

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Liabilities / assets	173.8%	Total Liabilities: 11582000 Open source Total Assets: 6664000 Open source
20102010-06-30	Liabilities / assets	607.3%	Total Liabilities: 30102000 Open source Total Assets: 4957000 Open source
20112011-06-30	Liabilities / assets	439.1%	Total Liabilities: 27051000 Open source Total Assets: 6160000 Open source
20122012-06-30	Liabilities / assets	619.6%	Total Liabilities: 38637000 Open source Total Assets: 6236000 Open source
20132013-06-30	Liabilities / assets	973.8%	Total Liabilities: 49646000 Open source Total Assets: 5098000 Open source
20142014-06-30	Liabilities / assets	1,217.1%	Total Liabilities: 66684000 Open source Total Assets: 5479000 Open source
20152015-06-30	Liabilities / assets	852.3%	Total Liabilities: 88569000 Open source Total Assets: 10392000 Open source
20162015-09-30	Liabilities / assets	675.4%	Total Liabilities: 91966000 Open source Total Assets: 13616000 Open source
20162016-06-30	Liabilities / assets	677.2%	Total Liabilities: 101213000 Open source Total Assets: 14945000 Open source
20172016-09-30	Liabilities / assets	783.6%	Total Liabilities: 110964000 Open source Total Assets: 14161000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.12× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-06-30	Current assets / current liabilities	0.17×	Current Assets: 1979000 Open source Current Liabilities: 11412000 Open source
20102010-06-30	Current assets / current liabilities	0.13×	Current Assets: 3812000 Open source Current Liabilities: 29757000 Open source
20112011-06-30	Current assets / current liabilities	0.21×	Current Assets: 5613000 Open source Current Liabilities: 26993000 Open source
20122012-06-30	Current assets / current liabilities	0.14×	Current Assets: 5542000 Open source Current Liabilities: 38604000 Open source
20132013-06-30	Current assets / current liabilities	0.09×	Current Assets: 4269000 Open source Current Liabilities: 49557000 Open source
20142014-06-30	Current assets / current liabilities	0.07×	Current Assets: 4431000 Open source Current Liabilities: 66476000 Open source
20152015-06-30	Current assets / current liabilities	0.11×	Current Assets: 9414000 Open source Current Liabilities: 88280000 Open source
20162015-09-30	Current assets / current liabilities	0.14×	Current Assets: 12629000 Open source Current Liabilities: 91611000 Open source
20162016-06-30	Current assets / current liabilities	0.14×	Current Assets: 13973000 Open source Current Liabilities: 100699000 Open source
20172016-09-30	Current assets / current liabilities	0.12×	Current Assets: 13220000 Open source Current Liabilities: 110317000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2008-07-01 – 2009-06-30	−USD 12.75 million Exact value Exact value: -12751000 USD 2008-07-01 – 2009-06-30: -12751000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2009-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -12751000 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: -12751000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000005.txt#13402 The citation records this snapshot. The page link may show a newer release later.	−USD 4.02 million Exact value Exact value: -4018000 USD 2008-07-01 – 2009-06-30: -4018000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2009-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -4018000 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4018000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000005.txt#13762 The citation records this snapshot. The page link may show a newer release later.	USD 103,000 Exact value Exact value: 103000 USD 2008-07-01 – 2009-06-30: 103000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Implant Sciences Corp · 2009-06-30 Implant Sciences Corp (edgar:1068874) Capital Expenditure: 103000 USD Concept: fundies:CapitalExpenditure Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ACapitalExpenditure&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 103000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000005.txt#13786 The citation records this snapshot. The page link may show a newer release later.	−USD 4.12 million Calculation and evidence -4018000 − 103000 USD Exact free cash flow: -4121000 USD 2008-07-01 – 2009-06-30: -4018000 USD · Inspect Operating Cash Flow · Source 2008-07-01 – 2009-06-30: 103000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Implant Sciences Corp · 2009-06-30 Implant Sciences Corp (edgar:1068874) Free cash flow: -4121000 USD Concept: free-cash-flow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4018000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000005.txt#13762 Input fundies:CapitalExpenditure: 103000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000005.txt#13786 The citation records this snapshot. The page link may show a newer release later.
2010 2009-07-01 – 2010-06-30	−USD 15.52 million Exact value Exact value: -15523000 USD 2009-07-01 – 2010-06-30: -15523000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2010-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -15523000 USD Concept: fundies:NetIncome Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:NetIncome: -15523000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11297 The citation records this snapshot. The page link may show a newer release later.	−USD 7.94 million Exact value Exact value: -7944000 USD 2009-07-01 – 2010-06-30: -7944000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2010-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -7944000 USD Concept: fundies:OperatingCashFlow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7944000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11621 The citation records this snapshot. The page link may show a newer release later.	USD 10,000 Exact value Exact value: 10000 USD 2009-07-01 – 2010-06-30: 10000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Implant Sciences Corp · 2010-06-30 Implant Sciences Corp (edgar:1068874) Capital Expenditure: 10000 USD Concept: fundies:CapitalExpenditure Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ACapitalExpenditure&period=2010-06-30&surface=latest&period_type=duration&start=2009-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11655 The citation records this snapshot. The page link may show a newer release later.	−USD 7.95 million Calculation and evidence -7944000 − 10000 USD Exact free cash flow: -7954000 USD 2009-07-01 – 2010-06-30: -7944000 USD · Inspect Operating Cash Flow · Source 2009-07-01 – 2010-06-30: 10000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Implant Sciences Corp · 2010-06-30 Implant Sciences Corp (edgar:1068874) Free cash flow: -7954000 USD Concept: free-cash-flow Period: 2009-07-01 to 2010-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7944000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11621 Input fundies:CapitalExpenditure: 10000 USD (2009-07-01 to 2010-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11655 The citation records this snapshot. The page link may show a newer release later.
2011 2010-07-01 – 2011-06-30	−USD 15.55 million Exact value Exact value: -15554000 USD 2010-07-01 – 2011-06-30: -15554000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2011-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -15554000 USD Concept: fundies:NetIncome Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:NetIncome: -15554000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11297 The citation records this snapshot. The page link may show a newer release later.	−USD 7.93 million Exact value Exact value: -7927000 USD 2010-07-01 – 2011-06-30: -7927000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2011-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -7927000 USD Concept: fundies:OperatingCashFlow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7927000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11621 The citation records this snapshot. The page link may show a newer release later.	USD 59,000 Exact value Exact value: 59000 USD 2010-07-01 – 2011-06-30: 59000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Implant Sciences Corp · 2011-06-30 Implant Sciences Corp (edgar:1068874) Capital Expenditure: 59000 USD Concept: fundies:CapitalExpenditure Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ACapitalExpenditure&period=2011-06-30&surface=latest&period_type=duration&start=2010-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11655 The citation records this snapshot. The page link may show a newer release later.	−USD 7.99 million Calculation and evidence -7927000 − 59000 USD Exact free cash flow: -7986000 USD 2010-07-01 – 2011-06-30: -7927000 USD · Inspect Operating Cash Flow · Source 2010-07-01 – 2011-06-30: 59000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Implant Sciences Corp · 2011-06-30 Implant Sciences Corp (edgar:1068874) Free cash flow: -7986000 USD Concept: free-cash-flow Period: 2010-07-01 to 2011-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7927000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11621 Input fundies:CapitalExpenditure: 59000 USD (2010-07-01 to 2011-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/0001068874-11-000035.txt#11655 The citation records this snapshot. The page link may show a newer release later.
2012 2011-07-01 – 2012-06-30	−USD 14.64 million Exact value Exact value: -14636000 USD 2011-07-01 – 2012-06-30: -14636000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2012-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -14636000 USD Concept: fundies:NetIncome Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:NetIncome: -14636000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887413000050/imsc-20130630.xml#18397 Filing: 000106887413000050 The citation records this snapshot. The page link may show a newer release later.	−USD 10.54 million Exact value Exact value: -10536000 USD 2011-07-01 – 2012-06-30: -10536000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2012-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -10536000 USD Concept: fundies:OperatingCashFlow Period: 2011-07-01 to 2012-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2012-06-30&surface=latest&period_type=duration&start=2011-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10536000 USD (2011-07-01 to 2012-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887413000050/imsc-20130630.xml#22964 Filing: 000106887413000050 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2012-07-01 – 2013-06-30	−USD 27.35 million Exact value Exact value: -27354000 USD 2012-07-01 – 2013-06-30: -27354000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2013-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -27354000 USD Concept: fundies:NetIncome Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:NetIncome: -27354000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887415000060/imsc-20150630.xml#15075 Filing: 000106887415000060 The citation records this snapshot. The page link may show a newer release later.	−USD 10.89 million Exact value Exact value: -10890000 USD 2012-07-01 – 2013-06-30: -10890000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2013-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -10890000 USD Concept: fundies:OperatingCashFlow Period: 2012-07-01 to 2013-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2013-06-30&surface=latest&period_type=duration&start=2012-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10890000 USD (2012-07-01 to 2013-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887415000060/imsc-20150630.xml#21852 Filing: 000106887415000060 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-07-01 – 2014-06-30	−USD 21.01 million Exact value Exact value: -21010000 USD 2013-07-01 – 2014-06-30: -21010000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2014-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -21010000 USD Concept: fundies:NetIncome Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:NetIncome: -21010000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887415000060/imsc-20150630.xml#14961 Filing: 000106887415000060 The citation records this snapshot. The page link may show a newer release later.	−USD 9.99 million Exact value Exact value: -9989000 USD 2013-07-01 – 2014-06-30: -9989000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2014-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -9989000 USD Concept: fundies:OperatingCashFlow Period: 2013-07-01 to 2014-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2014-06-30&surface=latest&period_type=duration&start=2013-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9989000 USD (2013-07-01 to 2014-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887415000060/imsc-20150630.xml#21681 Filing: 000106887415000060 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-07-01 – 2015-06-30	−USD 21.54 million Exact value Exact value: -21543000 USD 2014-07-01 – 2015-06-30: -21543000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2015-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -21543000 USD Concept: fundies:NetIncome Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:NetIncome: -21543000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000114/imsc-20160630.xml#31515 Filing: 000106887416000114 The citation records this snapshot. The page link may show a newer release later.	−USD 12.15 million Exact value Exact value: -12150000 USD 2014-07-01 – 2015-06-30: -12150000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2015-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -12150000 USD Concept: fundies:OperatingCashFlow Period: 2014-07-01 to 2015-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2015-06-30&surface=latest&period_type=duration&start=2014-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12150000 USD (2014-07-01 to 2015-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000114/imsc-20160630.xml#35933 Filing: 000106887416000114 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2014-10-01 – 2015-09-30	−USD 911,000 Exact value Exact value: -911000 USD 2014-10-01 – 2015-09-30: -911000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2015-09-30 Implant Sciences Corp (edgar:1068874) Net Income: -911000 USD Concept: fundies:NetIncome Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:NetIncome: -911000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#20387 Filing: 000106887416000139 The citation records this snapshot. The page link may show a newer release later.	−USD 1.27 million Exact value Exact value: -1268000 USD 2014-10-01 – 2015-09-30: -1268000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2015-09-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -1268000 USD Concept: fundies:OperatingCashFlow Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1268000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#13745 Filing: 000106887416000139 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-07-01 – 2016-06-30	−USD 10.66 million Exact value Exact value: -10655000 USD 2015-07-01 – 2016-06-30: -10655000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2016-06-30 Implant Sciences Corp (edgar:1068874) Net Income: -10655000 USD Concept: fundies:NetIncome Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:NetIncome: -10655000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000114/imsc-20160630.xml#31401 Filing: 000106887416000114 The citation records this snapshot. The page link may show a newer release later.	−USD 1.49 million Exact value Exact value: -1487000 USD 2015-07-01 – 2016-06-30: -1487000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2016-06-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -1487000 USD Concept: fundies:OperatingCashFlow Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1487000 USD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000114/imsc-20160630.xml#35762 Filing: 000106887416000114 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2015-10-01 – 2016-09-30	−USD 27.18 million Exact value Exact value: -27184000 USD 2015-10-01 – 2016-09-30: -27184000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Implant Sciences Corp · 2016-09-30 Implant Sciences Corp (edgar:1068874) Net Income: -27184000 USD Concept: fundies:NetIncome Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3ANetIncome&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:NetIncome: -27184000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#20273 Filing: 000106887416000139 The citation records this snapshot. The page link may show a newer release later.	−USD 40,000 Exact value Exact value: -40000 USD 2015-10-01 – 2016-09-30: -40000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Implant Sciences Corp · 2016-09-30 Implant Sciences Corp (edgar:1068874) Operating Cash Flow: -40000 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T19:12:30Z Snapshot: ea7dc095c9f8afa2a9b5267b986dcc374c316bfa76c3ba66396c908497a4d45b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1068874/explain?concept=fundies%3AOperatingCashFlow&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1068874/000106887416000139/imsc-20160930.xml#13576 Filing: 000106887416000139 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

115 filings · 1,479 latest values · 1,479 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001068874, 1068874, edgar:1068874, imsc, imscq

Also known as IMPLANT SCIENCE CORP, IMPLANT SCIENCES CORP, Implant Sciences Corp, Implant Sciences Corporation, SECURE POINT TECHNOLOGIES INC

Implant Sciences Corp

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2017 2015-10-01 – 2016-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation